GHSI’s 2026 H7N9 Fight: Lessons Learned
What did GHSI learn from the 2026 H7N9 Neo-Flu threat? Find out how rapid testing, data sharing, and 2 billion vaccine doses prevented disaster.
What did GHSI learn from the 2026 H7N9 Neo-Flu threat? Find out how rapid testing, data sharing, and 2 billion vaccine doses prevented disaster.
A 2025 flu vaccine delay signals a UK pharma shift. Learn why NHS faces a 2026 crisis & how changing guidelines impact supply.
Dementia care costs hit $1.7 trillion by 2030. Public funds can't keep up; private investment in tech, insurance, and startups is booming.
Global agri-biotech rules are diverging. Learn how EU, US, and African policies could spark trade disputes by 2027 and impact food security.
Are drug copay cards patient help or a marketing tool? Learn how these cards boost adherence by 15-20% but shift costs to health plans.
What's next for global trade? See 5 key tech shifts by 2026, like reducing recovery times by 50% with better cybersecurity. Why it matters now.
Iambic's AI drug alliance changes pharma development. See how AI speeds drug discovery, saving $2B+ per drug. What's next for oncology?
BioGen faced MFN audit scrutiny in 2026. Learn how automating data and clear governance can cut pharma claims audit risk by 30%.
Is global health ready for 2026? See how the WHO's Pandemic Accord, underfunded initiatives like the Global Fund, and digital health passports shape cross-b
By 2027, gene-edited maize will boost drought resistance and yields by 15-20%. See how this changes agribusiness and food security.